EXPERIENCE OF THE USE OF DEFERASIROX IN PAEDIATRIC PATIENTS WITH TRANSFUSIONAL DEPENDENCY

被引：0
|
作者：
Faci Cristina, Martinez [1 ]
Sanjuan Laura, Murillo [1 ]
Cebrian Flor, Yus [2 ]
Maria Angeles, Montanes Gracia [2 ]
Flores Maria Del Valle, Recasens [2 ]
Iturrate Carmen, Rodriguez-Vigil [1 ]
机构：
[1] Hosp Univ Miguel Servet, Serv Pediat, Zaragoza, Spain
[2] Hosp Univ Miguel Servet, Serv Hematol, Zaragoza, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-320
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [1] Renal Safety after More Than a Decade of Deferasirox Use in Patients with Transfusional Hemosiderosis
    Origa, Raffaella
    Piga, Antonio
    Tartaglione, Immacolata
    Della Corte, Giuseppina
    El-Ali, Ali
    Han, Jackie
    Castiglioni, Chiara
    Forni, Gian Luca
    BLOOD, 2016, 128 (22)
  • [2] RENAL SAFETY AFTER MORE THAN A DECADE OF DEFERASIROX USE IN PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS
    Origa, Raffaella
    Piga, Antonio
    Tartaglione, Immacolata
    Della Corte, Giuseppina
    Bruederle, Andreas
    Han, Jackie
    Castiglioni, Chiara
    Forni, Gian Luca
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E347 - E347
  • [3] Deferasirox: A guide to its use in transfusional chronic iron overload
    不详
    Drugs & Therapy Perspectives, 2008, 24 (2) : 1 - 4
  • [4] Deferasirox - A review of its use in the management of transfusional chronic iron overload
    Yang, Lily P. H.
    Keam, Susan J.
    Keating, Gillian M.
    DRUGS, 2007, 67 (15) : 2211 - 2230
  • [5] The Safety, Tolerability and Efficacy of Deferasirox in Older Patients with Transfusional Dependent Anemia
    Arboscello, Eleonora
    Del Corso, Lisette
    Giacchello, Jacopo Agnelli
    Balleari, Enrico
    Bellodi, Andrea
    Di Grazia, Carmen
    Dominietto, Alida
    Favorini, Serena
    Ghiso, Anna
    Giovannini, Martina
    Molinari, Elisa
    Salvetti, Chiara
    Sicbaldi, Vera
    Strada, Paolo
    Ubezio, Gianluca
    Van Lint, Maria Teresa
    Vignolo, Luana
    Ghio, Riccardo
    BLOOD, 2014, 124 (21)
  • [6] Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload
    Deugnier, Yves
    Turlin, Bruno
    Dong, Victor
    Giannone, Vanessa
    Zhang, Yiyun
    Griffel, Louis
    Brissot, Pierre
    BLOOD, 2010, 116 (21) : 1734 - 1735
  • [7] Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA
    Cheong, June-Won
    Kim, Hyeoung-Jocm
    Lee, Kyoo-Hyung
    Yoon, Sung-Soo
    Lee, Jae Hoon
    Park, Hee-Sook
    Kim, Jin Seok
    Kim, Ho Young
    Shim, Hyeok
    Seung, Chu-Myung
    Kim, Chul Soo
    Chung, Jooseop
    Hyun, Myung Soo
    Jo, Deog-Yeon
    Jung, Chul Won
    Sohn, Sang Kyun
    Yoon, Hwi-Joong
    Kim, Byung Soo
    Joo, Young-Don
    Park, Chi-Young
    Min, Yoo-Hong
    BLOOD, 2009, 114 (22) : 1466 - 1466
  • [8] 3 year experience of deferasirox in a small paediatric cohort of beta thalassaemia major patients
    Welch, J. C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 67 - 67
  • [9] Deferasirox for myelodysplastic syndrome patients with transfusional iron overload: A budget impact analysis
    Mody-Patel, N.
    Goldberg, S. L.
    Barghout, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload
    Yui, Jennifer C.
    Geara, Abdallah
    Sayani, Farzana
    VOX SANGUINIS, 2021, 116 (07) : 793 - 797
12345